| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.3M | -17.3% |
| Cost of Revenue | $10.1M | -5.4% |
| Gross Profit | $1.1M | -60.9% |
| R&D Expense | $320K | -31.9% |
| SG&A Expense | $4.8M | +30.0% |
| Operating Income | -$5.7M | -189.3% |
| Pre-tax Income | -$5.5M | -310.9% |
| Net Income | -$5.5M | -310.9% |
| EPS (Basic) | -$0.84 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.6M | +763.0% |
| Accounts Receivable | $3K | -98.5% |
| Inventory | $348K | -7.9% |
| Current Assets | $20.5M | +413.1% |
| Total Assets | $21.0M | +298.1% |
| Current Liabilities | $5.8M | +30.6% |
| Total Liabilities | $6.1M | +25.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | +0.6% |
| Capital Expenditures | $30K | -55.8% |
| Investing Cash Flow | -$28K | +50.8% |
| Financing Cash Flow | $19.7M | +527.4% |
| Free Cash Flow | -$3.2M | +1.7% |
| +63.9% |
| Stockholders' Equity |
| $14.9M |
| +517.2% |